Skip links

Author: Claudia Patricia Moreno Alzate

PharmaCielo Announces Q1 2023 Financial Results

May 29, 2023 The Company has products in various stages of testing and sales with more than 40 customers in 11 countries, with continued growth expected for the year. Q1 2023 revenue of $786,498; Adjusted EBITDA loss of $1.9 million. PharmaCielo continues to focus on